News

• PTA-News: Medigene AG: Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers
  02/26/2019 / 12:36 - pressetext
•  
• PTA-Adhoc: Medigene AG: Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers
  02/26/2019 / 12:35 - pressetext
•  
• PTA-News: Medigene AG: Medigene presents development strategies for TCR therapies at CAR-TCR Summit Europe
  02/26/2019 / 07:30 - pressetext
•  
• PTA-News: Medigene AG: European Patent covering TCR library suitable for the development of neoantigen-specific TCRs
  02/25/2019 / 07:30 - pressetext
•  
• PTA-News: Medigene AG: Medigene participates at upcoming conferences
  02/22/2019 / 07:30 - pressetext
•  
• PTA-News: Medigene AG: Medigene appoints Axel-Sven Malkomes as CFO/CBDO
  02/11/2019 / 07:30 - pressetext
•  
• PTA-News: Medigene AG: Medigene participates at four upcoming conferences
  01/17/2019 / 07:30 - pressetext
•  
• PTA-News: Medigene AG: Additional European patent granted for Medigene's DC vaccine platform
  01/08/2019 / 17:35 - pressetext
•  
• PTA-Adhoc: Medigene AG: Medigene publishes topline interim data from ongoing Phase I/II clinical trial with DC vaccines in AML patients
  12/19/2018 / 21:40 - pressetext
•  
• PTA-News: Medigene AG: Medigene participates at further upcoming conferences
  12/18/2018 / 07:30 - pressetext
•  
• PTA-News: Medigene AG: Medigene participates at further upcoming conferences
  11/20/2018 / 07:30 - pressetext
•  
• PTA-Adhoc: Medigene AG: Medigene Signs Exclusive License Agreement with Leiden University to Develop Novel T Cell Receptor
  11/12/2018 / 18:50 - pressetext
•  
• PTA-News: Medigene AG: Medigene participates at four conferences in November
  10/31/2018 / 07:30 - pressetext
•  
• PTA-News: Medigene AG: Medigene participates at four conferences in October
  10/02/2018 / 07:30 - pressetext
•  
• PTA-News: Dr. Hönle AG: Dr. Hönle AG is included in SDAX
  09/06/2018 / 16:50 - pressetext